Inovio Pharmaceuticals, INC. (INO) — 10-Q Filings

10-Q Filings (6)

• Inovio's Losses Widen Amidst Going Concern Doubts — Nov 10, 2025 Risk: high
  INOVIO PHARMACEUTICALS, INC. reported a significant increase in net loss for the three and nine months ended September 30, 2025, reaching $45.5 million and $88.
• INOVIO Narrows Q2 Loss to $30.5M Amid Pipeline Progress — Aug 12, 2025 Risk: high
  INOVIO PHARMACEUTICALS, INC. reported a net loss of $30.5 million for the second quarter of 2025, a significant improvement from the $45.2 million net loss in t
• INOVIO Pharmaceuticals Files Q1 2025 10-Q — May 13, 2025 Risk: medium
  INOVIO Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first
• INOVIO Pharmaceuticals Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  INOVIO Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial position and operational update
• INOVIO Pharmaceuticals Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  INOVIO Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported a net loss for the three and six months ended June 30, 202
• Inovio Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: medium
  INOVIO PHARMACEUTICALS, INC. (INO) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Inovio Pharmaceuticals, Inc. filed a 10-Q report for the period

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX